K Y Lee1, L L Latour, M Luby, A W Hsia, J G Merino, S Warach. 1. Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological Disorders and Stroke, 10 Center Drive, Room B1D733, Bethesda, MD 20892-1063, USA.
Abstract
BACKGROUND: Hyperintense vessels (HV) on fluid-attenuated inversion recovery imaging are frequently observed in acute ischemic stroke patients. However, the exact mechanism and clinical implications of this sign have not yet been clearly defined. The features of HV and its relevance to other imaging factors are presented here. METHODS: Prominence and location of HV were documented in 52 consecutive patients with middle cerebral artery (MCA) territory infarction, before treatment with IV recombinant tissue plasminogen activator. Pretreatment ischemic lesion volume, perfusion lesion volume, and vessel occlusion were determined in addition to recanalization status and ischemic lesion volume on follow-up imaging. NIH Stroke Scale (NIHSS) was used as a measure of clinical severity. RESULTS: HV distal to arterial occlusion was observed in 73% of patients; more frequent in proximal than distal MCA occlusion patients. Among the 38 patients with proximal MCA occlusion, initial perfusion lesion volume was comparable among patients with different grade distal HV. However, patients with more prominent distal HV had smaller initial, 24-hour, and subacute ischemic lesion volumes and lower initial NIHSS scores. CONCLUSIONS: The presence of distal hyperintense vessels before thrombolytic treatment is associated with large diffusion-perfusion mismatch and smaller subacute ischemic lesion volumes in patients with proximal middle cerebral artery occlusion. DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; GRE = gradient recalled echo; HV = hyperintense vessels; MCA = middle cerebral artery; MRA = magnetic resonance angiography; MTT = mean transit time; NIHSS = NIH Stroke Scale; PWI = perfusion-weighted imaging; rt-PA = recombinant tissue plasminogen activator; TE = echo time; TI = inversion time; TIMI = thrombolysis in myocardial infarction; TR = repetition time.
BACKGROUND: Hyperintense vessels (HV) on fluid-attenuated inversion recovery imaging are frequently observed in acute ischemic strokepatients. However, the exact mechanism and clinical implications of this sign have not yet been clearly defined. The features of HV and its relevance to other imaging factors are presented here. METHODS: Prominence and location of HV were documented in 52 consecutive patients with middle cerebral artery (MCA) territory infarction, before treatment with IV recombinant tissue plasminogen activator. Pretreatment ischemic lesion volume, perfusion lesion volume, and vessel occlusion were determined in addition to recanalization status and ischemic lesion volume on follow-up imaging. NIH Stroke Scale (NIHSS) was used as a measure of clinical severity. RESULTS: HV distal to arterial occlusion was observed in 73% of patients; more frequent in proximal than distal MCA occlusionpatients. Among the 38 patients with proximal MCA occlusion, initial perfusion lesion volume was comparable among patients with different grade distal HV. However, patients with more prominent distal HV had smaller initial, 24-hour, and subacute ischemic lesion volumes and lower initial NIHSS scores. CONCLUSIONS: The presence of distal hyperintense vessels before thrombolytic treatment is associated with large diffusion-perfusion mismatch and smaller subacute ischemic lesion volumes in patients with proximal middle cerebral artery occlusion. DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; GRE = gradient recalled echo; HV = hyperintense vessels; MCA = middle cerebral artery; MRA = magnetic resonance angiography; MTT = mean transit time; NIHSS = NIH Stroke Scale; PWI = perfusion-weighted imaging; rt-PA = recombinant tissue plasminogen activator; TE = echo time; TI = inversion time; TIMI = thrombolysis in myocardial infarction; TR = repetition time.
Authors: Jeroen Hendrikse; Catharina J M Klijn; Alexander C van Huffelen; L Jaap Kappelle; Jeroen van der Grond Journal: Cerebrovasc Dis Date: 2008-03-17 Impact factor: 2.762
Authors: E Assouline; K Benziane; D Reizine; J P Guichard; F Pico; J J Merland; M G Bousser; H Chabriat Journal: Cerebrovasc Dis Date: 2005-05-30 Impact factor: 2.762
Authors: Peter D Schellinger; Julio A Chalela; Dong-Wha Kang; Lawrence L Latour; Steven Warach Journal: AJNR Am J Neuroradiol Date: 2005-03 Impact factor: 3.825
Authors: S Flacke; H Urbach; E Keller; F Träber; A Hartmann; J Textor; J Gieseke; W Block; P J Folkers; H H Schild Journal: Radiology Date: 2000-05 Impact factor: 11.105
Authors: M Maeda; Y Koshimoto; H Uematsu; H Yamada; H Kimura; Y Kawamura; H Itoh; H Sakuma; K Takeda Journal: J Magn Reson Imaging Date: 2001-06 Impact factor: 4.813
Authors: Ricardo Mostany; Tara G Chowdhury; David G Johnston; Shiva A Portonovo; S Thomas Carmichael; Carlos Portera-Cailliau Journal: J Neurosci Date: 2010-10-20 Impact factor: 6.167
Authors: A Kufner; I Galinovic; V Ambrosi; C H Nolte; M Endres; J B Fiebach; M Ebinger Journal: AJNR Am J Neuroradiol Date: 2015-05-14 Impact factor: 3.825
Authors: M Gawlitza; U Quäschling; C Hobohm; J Otto; P Voigt; K-T Hoffmann; D Lobsien Journal: AJNR Am J Neuroradiol Date: 2014-05-08 Impact factor: 3.825